Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome

被引:79
作者
de Mello, Vanessa D. F. [1 ,2 ]
Kolehmainen, Marjukka [1 ]
Schwab, Ursula [1 ,3 ]
Ursula, Mager [1 ]
Laaksonen, David E. [3 ]
Pulkkinen, Leena [1 ]
Niskanen, Leo [3 ]
Gylling, Helena [1 ,3 ]
Atalay, Mustafa [4 ]
Rauramaa, Rainer [5 ,6 ]
Uusitupa, Matti [1 ]
机构
[1] Univ Kuopio, Food & Hlth Res Ctr, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland
[2] Univ Fed Rio Grande do Sul, Dept Internal Med, BR-90035003 Porto Alegre, RS, Brazil
[3] Kuopio Univ Hosp, Inst Med Internal Med, Kuopio 70211, Finland
[4] Univ Kuopio, Inst Biomed Physiol, FIN-70211 Kuopio, Finland
[5] Univ Kuopio, Kuopio Res Inst Exercise Med, FIN-70211 Kuopio, Finland
[6] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, Kuopio 70211, Finland
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2008年 / 57卷 / 02期
基金
芬兰科学院;
关键词
D O I
10.1016/j.metabol.2007.08.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammation is associated with obesity, the metabolic syndrome, and diabetes. No data are available on the effect of weight reduction on the gene expression of cytokines in immune cells in obesity and the metabolic syndrome. We assessed how long-term weight loss affects expression of cytokines in peripheral blood mononuclear cells (PBMCs) in individuals with impaired glucose metabolism and the metabolic syndrome. Data from 34 subjects randomized to either a weight reduction or a control group for a 33-week period were analyzed. The messenger RNA (mRNA) expression of interleukins (ILs) in PBMCs was measured using real-time polymerase chain reaction. Measures of insulin and glucose metabolism (intravenous and oral glucose tolerance tests), body composition, and circulating adipokines and inflammatory markers were also assessed. Weight reduction resulted in a decrease in the mRNA expression of IL-1 beta (IL1B), IL-1 receptor antagonist, and tumor necrosis factor a (P < .001) and an increase in expression of IL-6 (IL6) and IL-8 (P < .01). The increase in IL6 expression was associated with a decrease in fasting glycemia (r = -0.53, P < .01). Interestingly, the decrease in IL1B expression was correlated with an increase in insulin sensitivity index (r = -0.68, P < .01). In general, a decrease in circulating levels of adipokines and inflammatory markers was also observed after weight loss. Weight loss altered gene expression of cytokines related to inflammation and the immune response in PBMCs. Changes in IL6 mRNA expression were associated with changes in fasting glycemia. The decrease in IL-1 receptor antagonist expression after weight loss and the strong correlation between the decrease in IL1B expression and the increase in insulin sensitivity suggest a contribution of these genes to insulin-resistant states found in obesity and the metabolic syndrome. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 45 条
  • [21] Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study
    Laaksonen, DE
    Lakka, HM
    Niskanen, LK
    Kaplan, GA
    Salonen, JT
    Lakka, TA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (11) : 1070 - 1077
  • [22] The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
    Lakka, HM
    Laaksonen, DE
    Lakka, TA
    Niskanen, LK
    Kumpusalo, E
    Tuomilehto, J
    Salonen, JT
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (21): : 2709 - 2716
  • [23] Obesity and immunocompetence
    Lamas, O
    Marti, A
    Martínez, JA
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2002, 56 (Suppl 3) : S42 - S45
  • [24] The Finnish Diabetes Prevention Study (DPS)
    Lindstrom, J
    Louheranta, A
    Mannelin, M
    Rastas, M
    Salminen, V
    Eriksson, J
    Uusitupa, M
    Tuomilehto, J
    [J]. DIABETES CARE, 2003, 26 (12) : 3230 - 3236
  • [25] Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention:: follow-up of the Finnish Diabetes Prevention Study
    Lindstrom, Jaana
    Ilanne-Parikka, Pirjo
    Peltonen, Markku
    Aunola, Sirkka
    Eriksson, Johan G.
    Hemio, Katri
    Hamalainen, Helena
    Harkonen, Pirjo
    Keinanen-Kiukaanniemi, Sirkka
    Laakso, Mauri
    Louheranta, Anne
    Mannelin, Marjo
    Paturi, Merja
    Sundvall, Jouko
    Valle, Timo T.
    Uusitupa, Matti
    Tuomilehto, Jaakko
    [J]. LANCET, 2006, 368 (9548) : 1673 - 1679
  • [26] Leptin regulates proinflammatory immune responses
    Loffreda, S
    Yang, SQ
    Lin, HZ
    Karp, CL
    Brengman, ML
    Wang, DJ
    Klein, AS
    Bulkley, GB
    Bao, C
    Noble, PW
    Lane, MD
    Diehl, AM
    [J]. FASEB JOURNAL, 1998, 12 (01) : 57 - 65
  • [27] IL-1 receptor antagonist serum levels are increased in human obesity: A possible link to the resistance to leptin?
    Meier, CA
    Bobbioni, E
    Gabay, C
    Assimacopoulos-Jeannet, F
    Golay, A
    Dayer, JM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 1184 - 1188
  • [28] Lifestyle intervention according to general recommendations improves glucose tolerance
    Mensink, M
    Blaak, EE
    Corpeleijn, E
    Saris, WH
    de Bruin, TW
    Feskens, EJ
    [J]. OBESITY RESEARCH, 2003, 11 (12): : 1588 - 1596
  • [29] Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus
    Mito, N
    Hiyoshi, T
    Hosoda, T
    Kitada, C
    Sato, K
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2002, 56 (04) : 347 - 351
  • [30] Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo
    Mohamed-Ali, V
    Goodrick, S
    Rawesh, A
    Katz, DR
    Miles, JM
    Yudkin, JS
    Klein, S
    Coppack, SW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 4196 - 4200